Akihiro Kondo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akihiro Kondo has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Takatoshi Nakagawa
Department of Glycotherapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Osaka 565-0871, Japan
4 shared publicationsEiji Miyoshi
Department of Glycotherapeutics, Department of Functional Diagnostic Science, Division of Health Science, Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Osaka 565-0871, Japan and Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan
3 shared publicationsNaoyuki Taniguchi
Department of Glycotherapeutics, Department of Functional Diagnostic Science, Division of Health Science, Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Osaka 565-0871, Japan and Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan
3 shared publicationsJinhua Jin
Departments of Biochemistry , Osaka University Graduate School of Medicine , Osaka 565-0871 , Japan
2 shared publicationsNobuto Koyama
Takara Bio Inc. Shiga 520-2193 , Japan
2 shared publicationsWenzhe Li
Department of Glycotherapeutics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
2 shared publications
Latest Publications
- 15 May 2008
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 7 (6) , 2222-2233
Glycomic Analysis of Alpha-Fetoprotein L3 in Hepatoma Cell Lines and Hepatocellular Carcinoma Patients
The N-glycan structures of the Lens culinaris agglutinin (LCA)-reactive fraction of alpha-fetoprotein (AFP-L3), a tumor marker of hepatocellular carcinomas (HCC), were analyzed in relationship to glycosyltransferases and LCA-affinity electrophoresis. Using HPLC and MALDI-TOF MS, we determined the N-glycan structures of AFP from HCC cell lines, and demonstrated they were affected by N-acetylglucosaminyltransferase III and fucosyltransferase VIII, but not by N-acetylglucosaminyltransferase V. Moreover, we identified the N-glycan structures of AFP in HCC patients.
- 15 May 2008
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 7 (6) , 2222-2233
Glycomic Analysis of Alpha-Fetoprotein L3 in Hepatoma Cell Lines and Hepatocellular Carcinoma Patients
The N-glycan structures of the Lens culinaris agglutinin (LCA)-reactive fraction of alpha-fetoprotein (AFP-L3), a tumor marker of hepatocellular carcinomas (HCC), were analyzed in relationship to glycosyltransferases and LCA-affinity electrophoresis. Using HPLC and MALDI-TOF MS, we determined the N-glycan structures of AFP from HCC cell lines, and demonstrated they were affected by N-acetylglucosaminyltransferase III and fucosyltransferase VIII, but not by N-acetylglucosaminyltransferase V. Moreover, we identified the N-glycan structures of AFP in HCC patients.
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4) , A-195-195
S1179 IgG Oligosaccharide Alterations Are a Novel Diagnostic Marker for Disease Activity and the Clinical Course of Inflammatory Bowel Disease
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4) , A-195-195
S1179 IgG Oligosaccharide Alterations Are a Novel Diagnostic Marker for Disease Activity and the Clinical Course of Inflammatory Bowel Disease
- Open Access
- 2 October 2007
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 18 (1) , 114-124
Reduced 4 1 Integrin/VCAM-1 Interactions Lead to Impaired Pre-B Cell Repopulation in Alpha 1,6-Fucosyltransferase Deficient Mice
Mice with a targeted gene disruption of Fut8 (Fut8−/−) showed an abnormality in the transition from pro-B cell to pre-B cell, reduced peripheral B cells, and a decreased immunoglobulin production. Alpha 1,6-fucosyltransferase (FUT8) is responsible for the alpha 1,6 core fucosylation of N-glycans, which could modify the functions of glycoproteins. The loss of a core fucose in both very late antigen 4 (VLA-4, α4β1 integrin) and vascular cell adhesion molecule 1 (VCAM-1) led to a decreased binding between pre-B cells and stromal cells, which impaired pre-B cells generation in Fut8−/− mice. Moreover, the B lineage genes, such as CD79a, CD79b, Ebf1, and Tcfe2a, were downregulated in Fut8−/− pre-B cells. Indeed, the frequency of preBCR+CD79blow cells in bone marrow pre-B cells in Fut8−/− was much lower than that in Fut8+/+ cells. These results reveal a new role of core fucosylated N-glycans in mediating early B cell development and functions.
- 2 October 2007
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 18 (1) , 114-124
Open AccessReduced 4 1 Integrin/VCAM-1 Interactions Lead to Impaired Pre-B Cell Repopulation in Alpha 1,6-Fucosyltransferase Deficient Mice
Mice with a targeted gene disruption of Fut8 (Fut8−/−) showed an abnormality in the transition from pro-B cell to pre-B cell, reduced peripheral B cells, and a decreased immunoglobulin production. Alpha 1,6-fucosyltransferase (FUT8) is responsible for the alpha 1,6 core fucosylation of N-glycans, which could modify the functions of glycoproteins. The loss of a core fucose in both very late antigen 4 (VLA-4, α4β1 integrin) and vascular cell adhesion molecule 1 (VCAM-1) led to a decreased binding between pre-B cells and stromal cells, which impaired pre-B cells generation in Fut8−/− mice. Moreover, the B lineage genes, such as CD79a, CD79b, Ebf1, and Tcfe2a, were downregulated in Fut8−/− pre-B cells. Indeed, the frequency of preBCR+CD79blow cells in bone marrow pre-B cells in Fut8−/− was much lower than that in Fut8+/+ cells. These results reveal a new role of core fucosylated N-glycans in mediating early B cell development and functions.
- Open Access
- 21 July 2006
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 16 (10) , 1007-1019
Down-regulation of trypsinogen expression is associated with growth retardation in α1,6-fucosyltransferase-deficient mice: attenuation of proteinase-activated receptor 2 activity
Alpha1,6-fucosyltransferase (Fut8) plays important roles in physiological and pathological conditions. Fut8-deficient (Fut8−/−) mice exhibit growth retardation, earlier postnatal death, and emphysema-like phenotype. To investigate the underlying molecular mechanism by which growth retardation occurs, we examined the mRNA expression levels of Fut8−/− embryos (18.5 days postcoitum [dpc]) using a cDNA microarray. The DNA microarray and real-time polymerase chain reaction (PCR) analysis showed that a group of genes, including trypsinogens 4, 7, 8, 11, 16, and 20, were down-regulated in Fut8−/− embryos. Consistently, the expression of trypsinogen proteins was found to be lower in Fut8−/− mice in the duodenum, small intestine, and pancreas. Trypsin, an active form of trypsinogen, regulates cell growth through a G-protein-coupled receptor, the proteinase-activated receptor 2 (PAR-2). In a cell culture system, a Fut8 knockdown mouse pancreatic acinar cell carcinoma, TGP49-Fut8-KDs, showed decreased growth rate, similar to that seen in Fut8−/− mice, and the decreased growth rate was rescued by the application of the PAR-2-activating peptide (SLIGRL-NH2). Moreover, epidermal growth factor (EGF)-induced receptor phosphorylation was attenuated in TGP49-Fut8-KDs, which was highly associated with a reduction of trypsinogens mRNA levels. The addition of exogenous EGF recovered c-fos, c-jun, and trypsinogen mRNA expression in TGP49-Fut8-KDs. Again, the EGF-induced up-regulation of c-fos and c-jun mRNA expression was significantly blocked by the protein kinase C (PKC) inhibitor. Our findings clearly demonstrate a relationship between Fut8 and the regulation of EGF receptor (EGFR)-trypsin-PAR-2 pathway in controlling cell growth and that the EGFR-trypsin-PAR-2 pathway is suppressed in TGP49-Fut8-KDs as well as in Fut8−/− mice.
- 21 July 2006
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 16 (10) , 1007-1019
Open AccessDown-regulation of trypsinogen expression is associated with growth retardation in α1,6-fucosyltransferase-deficient mice: attenuation of proteinase-activated receptor 2 activity
Alpha1,6-fucosyltransferase (Fut8) plays important roles in physiological and pathological conditions. Fut8-deficient (Fut8−/−) mice exhibit growth retardation, earlier postnatal death, and emphysema-like phenotype. To investigate the underlying molecular mechanism by which growth retardation occurs, we examined the mRNA expression levels of Fut8−/− embryos (18.5 days postcoitum [dpc]) using a cDNA microarray. The DNA microarray and real-time polymerase chain reaction (PCR) analysis showed that a group of genes, including trypsinogens 4, 7, 8, 11, 16, and 20, were down-regulated in Fut8−/− embryos. Consistently, the expression of trypsinogen proteins was found to be lower in Fut8−/− mice in the duodenum, small intestine, and pancreas. Trypsin, an active form of trypsinogen, regulates cell growth through a G-protein-coupled receptor, the proteinase-activated receptor 2 (PAR-2). In a cell culture system, a Fut8 knockdown mouse pancreatic acinar cell carcinoma, TGP49-Fut8-KDs, showed decreased growth rate, similar to that seen in Fut8−/− mice, and the decreased growth rate was rescued by the application of the PAR-2-activating peptide (SLIGRL-NH2). Moreover, epidermal growth factor (EGF)-induced receptor phosphorylation was attenuated in TGP49-Fut8-KDs, which was highly associated with a reduction of trypsinogens mRNA levels. The addition of exogenous EGF recovered c-fos, c-jun, and trypsinogen mRNA expression in TGP49-Fut8-KDs. Again, the EGF-induced up-regulation of c-fos and c-jun mRNA expression was significantly blocked by the protein kinase C (PKC) inhibitor. Our findings clearly demonstrate a relationship between Fut8 and the regulation of EGF receptor (EGFR)-trypsin-PAR-2 pathway in controlling cell growth and that the EGFR-trypsin-PAR-2 pathway is suppressed in TGP49-Fut8-KDs as well as in Fut8−/− mice.